PEOPLE - Elekta announces management changes for next year:
This article was originally published in Clinica
Radiation, oncology and neurosurgery solutions provider Elekta has announced a management reshuffle that will take effect in May 2005. Tomas Puusepp will become president and CEO, succeeding Laurent Leksell, who assumes a new role as executive director. Mr Puusepp joined Elekta in 1988, and is currently head of sales, marketing and service operations for the Stockholm, Sweden-based firm. Gerry van Oortmarssen, Elekta's head of European sales, will become executive vice-president of worldwide sales, marketing and service.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.